TCF7 and melanoma: Indeed, a human equivalent population of exhausted CD8+ TCF-7+ (the human ortholog of TCF-1) T cells have been found to predict positive responses to anti-PD-1 immunotherapy and enhanced survival of melanoma patients (17).